Scientific Validation & Testing

Scientific Validation & Testing
Science-Driven, Transparent, and Measured
Longevity Air is grounded in established virucidal copper research and validated airflow engineering.
Current Validation Work
Airflow Testing
Airflow and pressure-drop testing completed
Material Performance
Material performance grounded in peer-reviewed copper research
Pilot Deployments
Pilot deployments underway in real-world environments
Biological Testing
Expanded biological challenge testing in progress
Longevity Air does not rely on black-box claims. Validation is ongoing, measured, and documented.
What Validation Means—and What It Does Not
Validation confirms engineering performance and material behavior under defined conditions. It does not imply clinical outcomes or medical claims.
This distinction is central to Longevity Air's regulatory and commercial posture.
Peer-Reviewed Scientific Validation
Evidence-Based Science Behind Virucidal Air Filtration
Longevity Air's technology is built on established virology and materials science. Multiple peer-reviewed studies and official government validation demonstrate that copper and copper-based materials can inactivate viruses on contact, including coronaviruses and norovirus surrogates.
This body of evidence supports the fundamental mechanism Longevity Air uses—structural copper contact surfaces within air filtration architecture—to enable system-level reductions in viral viability as air recirculates.
Below are key studies supporting this mechanism. Click each card to explore the research directly.
Research Highlights
Study 1: Human Coronavirus 229E Inactivated on Copper
Warnes et al. (2015), mBio
Copper alloy surfaces rapidly inactivate human coronavirus 229E, destroying viral genomes and structural integrity, while control surfaces like stainless steel show persistent viable virus.
Full paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659470/
Key insight: Human coronavirus is significantly less stable on copper than on inert materials, demonstrating copper's inherent antiviral effect.
EPA Registration: Copper Alloys with Residual Antiviral Activity
U.S. Environmental Protection Agency (2021)
The EPA amended registrations for high-copper alloys (≥95.6%) to allow claims of residual antiviral activity against SARS-CoV-2 based on standardized EPA testing.
EPA announcement: https://www.epa.gov/newsreleases/epa-registers-copper-surfaces-residual-use-against-coronavirus
Key insight: Regulatory validation that certain copper alloys can inactivate SARS-CoV-2 under EPA test conditions.
Independent Report: Copper Coating Reduces SARS-CoV-2
Independent academic report (2020)
Surfaces coated with copper showed reduced viability of SARS-CoV-2 in laboratory simulations, with measurable decreases in viral load within 60 minutes.
Article: https://www.europeanpharmaceuticalreview.com/news/173625/copper-coated-surfaces-found-to-reduce-covid-19-transmission/
Key insight: Practical surface applications of copper reduce coronavirus viability in controlled exposure scenarios.
Murine Norovirus Inactivation on Copper Alloys
Warnes et al. (2013), PLOS ONE
Murine norovirus—a surrogate for human norovirus—was rapidly inactivated on dry copper alloy surfaces, while stainless steel showed no inactivation.
Full paper: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075017
Key insight: Copper's antiviral action extends beyond enveloped viruses, applying to non-enveloped viruses commonly used as conservative surrogates in infection control research.
SARS-CoV-2 Inactivation by Copper Oxide Coatings
Behzadinasab et al. (2020), ACS Applied Materials & Interfaces
Surfaces coated with copper(I) oxide (Cu₂O) achieved >99.9% reduction in SARS-CoV-2 titer within 1 hour of contact under controlled test conditions.
Full paper: https://pubs.acs.org/doi/10.1021/acsami.0c11425
Key insight: Copper-based surface treatments can dramatically reduce viable coronavirus under laboratory conditions.
What This Means
These studies provide independent, peer-reviewed evidence of copper's antiviral activity on contact surfaces under defined conditions. While most research focuses on surface contact, Longevity Air applies the same material principle within an airflow environment:
Copper surfaces disrupt viral integrity upon repeated encounters
Recirculating air increases opportunities for contact
System-level viral viability reduction is a function of airflow, runtime, and exposure opportunities
This aligns with how buildings actually operate and is consistent with the scientific evidence base.
Claims-Safe Interpretation
Copper and copper-based materials have been independently shown to inactivate viruses in controlled tests. Longevity Air applies this validated material mechanism within its air filter architecture so that circulating air repeatedly encounters virucidal surfaces, supporting a reduction in viable airborne viral load over time.
Next in Validation
Longevity Air is advancing beyond foundational material science through:
Airflow performance testing
Biological challenge testing under airflow conditions
Durability and long-term fouling assessments
Field pilots in real environments
These efforts are part of a rigorous validation roadmap designed to link material science to real-world performance.
Additional Resources
EPA copper antiviral registration: https://www.epa.gov/newsreleases/epa-registers-copper-surfaces-residual-use-against-coronavirus
mBio (Warnes coronavirus study): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659470/
PLOS ONE (norovirus copper study): https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075017
ACS Applied Materials & Interfaces (copper oxide inactivation): https://pubs.acs.org/doi/10.1021/acsami.0c11425
European Pharmaceutical Review (independent copper coating report): https://www.europeanpharmaceuticalreview.com/news/173625/copper-coated-surfaces-found-to-reduce-covid-19-transmission/